Surface Oncology
is a Massachusetts-based clinical-stage immuno-oncology company that researches and develops antibody therapies for the treatment of cancer... Read moreSurface Oncology
is a Massachusetts-based clinical-stage immuno-oncology company that researches and develops antibody therapies for the treatment of cancer... Read more
News
Sep 13, 2023
MarketScreener
Surface Oncology: Surface Oncology, Inc.(NasdaqCM:SURF) dropped from S&P Global BMI Index
Sep 11, 2023
Pharamceutical Technology
Surface Oncology: Coherus acquires immuno-oncology company Surface
Aug 07, 2023
Business Wire
Press Release: Surface Oncology : SURFACE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surface Oncology, Inc. - SURF
Aug 02, 2023
Benzinga
Surface Oncology: Surface Oncology Q2 EPS $(0.46) Misses $(0.34) Estimate
Aug 02, 2023
Marketscreener
Surface Oncology: Surface Oncology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Jul 28, 2023
centralcharts
Press Release: Surface Oncology : SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SURF, RETA, INPX
Jul 03, 2023
MarketScreener
Surface Oncology: Surface Oncology : Report of Independent Registered Public Accounting Firm - Form 8-K
Jun 22, 2023
The Business Journals
Surface Oncology: The Petri Dish: Surface Oncology to be acquired; Bayer promotes new U.S. head
Jun 21, 2023
Picante Today
Surface Oncology: SURFACE ONCOLOGY INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surface Oncology, Inc. - SURF
Jun 20, 2023
NewsFile
Press Release: Surface Oncology : SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Surface Oncology, Inc. Buyout
